Author: GlobeNewswire

NEW HAVEN, Conn., Nov. 25, 2024 (GLOBE NEWSWIRE) — Arvinas, Inc. (Nasdaq: ARVN) today announced that three posters for vepdegestrant,…

Webcast planned for Monday, November 25th at 8:00 AM ETAUSTIN, Texas, Nov. 24, 2024 (GLOBE NEWSWIRE) — Cassava Sciences, Inc.…

– Attruby is the first and only approved product with a label specifying near-complete stabilization of TTR. Attruby has been…

CANTON, Mass., Nov. 22, 2024 (GLOBE NEWSWIRE) — Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on…

LAS VEGAS, Nov. 21, 2024 (GLOBE NEWSWIRE) — BioAdaptives Inc. (OTC: BDPT) ushered in a new direction by appointing James…

DXS INTERNATIONAL PLC (AQSE: DXSP) Notice of 2024 Annual General Meeting The Board of DXS International plc (“the Company” or…

NEW HAVEN, Conn., Nov. 21, 2024 (GLOBE NEWSWIRE) — BioXcel Therapeutics, Inc. (the “Company”) (Nasdaq: BTAI), a biopharmaceutical company utilizing…

WOODRIDGE, Ill., Nov. 21, 2024 (GLOBE NEWSWIRE) — High Haven Dispensary, recognized as Illinois’ top-rated cannabis retailer, invites cannabis enthusiasts…

RICHMOND, Calif., Nov. 21, 2024 (GLOBE NEWSWIRE) — BioAge Labs (Nasdaq: BIOA) (“BioAge”, “the Company”), a clinical-stage biopharmaceutical company developing…

Conference Call to be held on December 3, 2024WINNIPEG, Manitoba, Nov. 21, 2024 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX-…